ACA
ZYME icon

Apis Capital Advisors’s Zymeworks ZYME Stock Holding History

Apis Capital Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$496K Sell
20,000
-5,000
-20% -$125K 0.78% 25
2019
Q2 		$550K Buy
+25,000
New +$459K 0.82% 25

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Apis Capital Advisors's ZYME Position: Q3 2019 in Review

Apis Capital Advisors reduced its Zymeworks (ZYME) stake by 20% in Q3 2019, selling an estimated $125K and leaving 20,000 shares worth $496K. The position accounts for 0.78% of the portfolio, ranked #25.

Apis Capital Advisors first reported a position in ZYME in Q2 2019 and has held it in 2 quarters since. The position peaked at $550K in Q2 2019. 74 funds tracked by Wall St. Rank hold ZYME as of Q3 2019.

  • Apis Capital Advisors held 20,000 shares of Zymeworks worth $496K as of Q3 2019.
  • Apis Capital Advisors sold 5,000 Zymeworks shares in Q3 2019, an estimated $125K.
  • Zymeworks made up 0.78% of Apis Capital Advisors's portfolio in Q3 2019, its #25 holding.
  • Apis Capital Advisors first reported a position in Zymeworks in Q2 2019 and has held it in 2 quarters since.
  • Apis Capital Advisors's Zymeworks position peaked at $550K in Q2 2019.
  • 74 funds tracked by Wall St. Rank held Zymeworks as of Q3 2019.

Based on Apis Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.